Melan-A/MART-1-specific CD8 T cells: from thymus to tumor.
Pittet
Mikaël J
MJ
Division of Clinical Onco-Immunology, Ludwig Institute for Cancer Research, University Hospital (CHUV), 1011 Lausanne, Switzerland.
Zippelius
Alfred
A
Valmori
Danila
D
Speiser
Daniel E
DE
Cerottini
Jean-Charles
JC
Romero
Pedro
P
D000951:Antigens, Neoplasm; D001324:Autoantigens / Q000276:immunology*; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology*; D019496:Cancer Vaccines / Q000276:immunology; D006412:Hematopoietic Stem Cells / Q000276:immunology; D006801:Humans; D058965:MART-1 Antigen; D008545:Melanoma / Q000276:immunology* / Q000517:prevention & control; D009363:Neoplasm Proteins / Q000276:immunology*; D013950:Thymus Gland / Q000276:immunology*
D000951:Antigens, Neoplasm; D001324:Autoantigens; D019496:Cancer Vaccines; D058965:MART-1 Antigen; C548667:MLANA protein, human; D009363:Neoplasm Proteins